BiomX (NYSEMKT:PHGE) Stock Price Up 6.6%

BiomX Inc. (NYSEMKT:PHGEGet Free Report) was up 6.6% on Friday . The stock traded as high as $0.24 and last traded at $0.23. Approximately 128,946 shares were traded during mid-day trading, an increase of 88% from the average daily volume of 68,601 shares. The stock had previously closed at $0.21.

BiomX Price Performance

The company has a current ratio of 2.84, a quick ratio of 2.84 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $10.35 million, a price-to-earnings ratio of -0.35 and a beta of 1.26. The business has a 50-day moving average price of $0.26 and a two-hundred day moving average price of $0.33.

Institutional Trading of BiomX

Several large investors have recently added to or reduced their stakes in the business. Renaissance Technologies LLC increased its position in shares of BiomX by 149.7% during the 2nd quarter. Renaissance Technologies LLC now owns 195,495 shares of the company’s stock valued at $70,000 after purchasing an additional 117,195 shares during the period. Susquehanna International Group LLP increased its position in shares of BiomX by 372.4% during the 1st quarter. Susquehanna International Group LLP now owns 195,598 shares of the company’s stock valued at $60,000 after purchasing an additional 154,189 shares during the period. Millennium Management LLC increased its position in shares of BiomX by 208.6% during the 4th quarter. Millennium Management LLC now owns 270,848 shares of the company’s stock valued at $51,000 after purchasing an additional 183,091 shares during the period. Finally, Jane Street Group LLC acquired a new position in shares of BiomX during the 1st quarter valued at $48,000. 36.67% of the stock is currently owned by institutional investors and hedge funds.

About BiomX

(Get Free Report)

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).

Featured Articles

Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.